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Abstract
Background. In 2014, Joint Commission recommended palliative care (PC) engagement in ventricular assist device (VAD)
implantation as destination therapy. Limited information is available on established PC protocols in the mechanical
circulatory support (MCS) population.
Measures. The goals of our PC consultation were to document advance care planning (ACP) discussions and designate a
surrogate decision maker (SDM) before MCS implantation. A retrospective analysis compared the frequency of PC consults,
ACP discussion, and SDM before and after protocol implementation.
Intervention. A protocol was developed to conduct interdisciplinary PC consultations for the MCS population.
Outcomes. The percentage of PC consults placed before MCS implantation increased from 11 (17.2%) before protocol to
56 (96.6%) after protocol (P < 0.0001) and documented SDM increased from 26 (40.6%) before protocol to 57 (98.3%) after
protocol (P < 0.0001).
Conclusions. Close PC/cardiology collaboration can substantially improve ACP discussions and SDM documentation in
the MCS population. This multidisciplinary protocol facilitates successful PC consultations. J Pain Symptom Manage
2017;54:583e588. ! 2017 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
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Background
Approximately 5.7 million Americans are currently
diagnosed with heart failure with about 300,000
deaths per year. The prevalence has doubled over
the last 25 years and is estimated to double again be-
tween 2030 and 2040 with the aging of the popula-
tion.1 When patients fail to respond to medical
therapies, they are considered for advanced therapies
such as heart transplant and mechanical circulatory
support (MCS) devices. The two-year survival for
continuous-flow ventricular assist devices (VADs) in
patients with low risk of complications has been shown
to parallel that of cardiac transplantation, with pa-
tients reporting improved quality of life and func-
tional capacity.2 However, the majority of patients are
at an increased risk of complications such as bleeding,
infection, stroke, pump thrombosis, and respiratory
failure among others.3 These can add significant stress
and symptom burden to patients and their families. In
addition, the patients getting these devices as
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destination therapy (DT) will face the end of life with
the VAD in place. Because of the need for advance
care planning (ACP) and symptom management, the
Centers for Medicare and Medicaid Services and The
Joint Commission recommended in 2014 that a pallia-
tive care (PC) representative experienced with the
VAD population be part of the interdisciplinary team
based on patient and family needs.4
Swetz et al. proposed that a preparedness plan/ACP
should be incorporated as part of a PC evaluation in
this population.5 Advance care plans support care
congruent to patients stated preferences.6 However,
limited information is available on established PC pro-
tocols and metrics in the MCS population. Before our
protocol intervention, very few patients receiving MCS
at our institution had an ACP and rarely was the PC
team involved in their care.
We developed and implemented a collaborative pro-
tocol between the PC team and the VAD team to ensure
a multidisciplinary approach and timely PC consulta-
tion for all patients being considered for MCS implan-
tation. Our protocol included all patients being
evaluated for MCS regardless of whether they were
DTor bridge to transplant (BTT) and even included to-
tal artificial heart patients. Because of the complex
needs of this patient population, we incorporated an
interdisciplinary team approach to our PC consulta-
tion. We sought to assess whether our collaborative
approach resulted in a significant increase in the
completion of an interdisciplinary PC consult and
documentation of a surrogate decision maker (SDM).
Measures/Interventions
Intervention
On March 1, 2014, a standardized PC consultation
protocol for all MCS candidates was implemented at
our institution (Fig. 1). Our goal was to complete an
interdisciplinary PC consultation on all patients before
MCS implantation. This protocol relied on close collab-
oration between heart failure specialists, cardiothoracic
surgeons, and PC specialists to enable timely and effec-
tive PC evaluations. This was elemental to the success of
our intervention and required active engagement in
the planning stage from both teams. The clinical nurse
coordinators from both the PC and cardiology teams
were designated as main contact persons to ensure
consistent, shared communication. We developed a
routine quarterly meeting between the teams to pro-
vide ongoing feedback and review of the protocol.
We also participated in the weekly interdisciplinary
team discussions for patients either with implanted
MCS or undergoing evaluation for the same.
Identification of Patients. The Cardiology team iden-
tifies patients being evaluated for MCS implantation
and then generates an electronic medical record alert
for PC consult before implant. The protocol includes
both DT and BTT designated patients as well as total
artificial heart patients. Including both DT and BTT
patients is advantageous, as BTT patients can experi-
ence future complications that would remove them
from transplant consideration.7
Content of the PC Consultation. After the cardiology
team enters an electronic medical record alert for
PC consultation, there is direct communication be-
tween nurse coordinators on both teams to share
pertinent information before evaluation. PC consulta-
tions incorporate visits from the interdisciplinary team
which includes PC trained physicians or advanced
practice nurses, PC social worker, and PC chaplain.
Goals of the PC consultation are to facilitate identi-
fication and documentation of an SDM, to assist with
ACP needs and to provide symptom-based physical,
emotional, psychosocial, and spiritual support to the
patient and/or their family members. For this report,
ACP is defined as discussing medical care that a
Assessment by 
interdisciplinary PC Team
Emotional & spiritual support 
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cardiology team and PC team
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Fig. 1. Palliative care and cardiology protocol diagram. ACP ¼ advance care planning; MCS ¼mechanical circulatory support;
PC ¼ palliative care.
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patient would like to receive in the future in the event
the patient is unable to speak for him or herself. ACP
discussions are documented in a formatted PC clinical
note, and advanced directives, including the SDM
document, are scanned and saved in a fixed section
for advanced directive in the electronic medical re-
cord for easy access. The existing PC inpatient consul-
ting team is primarily used as our resource, and
therefore, patients are seen when admitted to the hos-
pital often when undergoing preparation for implan-
tation. The PC team is not always part of the early
decision-making process as patients are often
admitted with the intent to implant an MCS.
Our model includes an interdisciplinary and
ongoing assessment by the PC clinician as well as the
PC social worker and chaplain to address psychosocial
and spiritual needs both before and after implanta-
tion. Visits are tailored according to the identified
needs of the patient and family. In several cases, we
have identified psychosocial and spiritual needs to
be greater than the medical needs. Examples of psy-
chosocial needs include adjustment to illness, grief
over loss of independence, and caregiver support.
Our PC consultation is not just limited to a preoper-
ative consultation. After the initial evaluation, the PC
team continues to work collaboratively with the car-
diac team throughout MCS workup and after MCS im-
plantation with regular patient visits. The protocol
relies on PC involvement both before and after device
implantation to ensure continuity of care and is not
limited to ACP alone.
Measures
A retrospective pre/post analysis was done to assess
this protocol and its quality improvement impact.
Chart review was performed on all patients who
received MCS devices at our academic health center.
The analysis included two observation periods: before
the implementation of the standardized PC consulta-
tion protocol (pre-PC protocol) from January 1,
2012, to February 28, 2014, and after implementation
(post-PC protocol) from March 1, 2014, to December
31, 2015. Approval was obtained from the Indiana
University Institutional Review Board for future study
implications.
Patient demographic characteristics were obtained
from the retrospective chart review. Detailed informa-
tion about involvement of the PC team was also re-
corded, including presence of PC consult before and
after implantation, presence of documented SDM
before and after MCS implantation, members of the
PC team involved in the patient’s care before and after
MCS implantation, physical location of death for
deceased patients, and PC team or hospice involve-
ment at the time of death.
Statistical Analysis
For both demographic and participant outcomes,
Student’s t-tests were performed for continuous vari-
ables to look for differences between groups (pre- vs.
post-PCC protocol). All analytic assumptions were veri-
fied, and Wilcoxon nonparametric tests were per-
formed when continuous variables were determined
to be nonlinear. For categorical variables, Fisher’s
exact tests were used to determine if there was signif-
icant heterogeneity between groups, due to low cell
counts. All analyses were performed using SAS v9.4
(SAS Institute, Cary, NC).
Outcomes
Demographics
There were 122 patients implanted with MCS de-
vices from January 1, 2012, to December 31, 2015,
with 64 pre-protocol and 58 post-protocol patients
(Table 1). The group before protocol implementation
included more women (39.1% vs. 20.7%, P ¼ 0.0315)
and small differences in marital status (P ¼ 0.0497).
The two groups were similar in other demographics.
Mean age was 57.73 " 12.85 years and
54.86 " 12.85 years for pre- and post-protocol groups,
respectively. Hospital lengths of stay were skewed, and
so are given with median (range), and are 30.6 days
(13.2e148.9) and 30.1 days (0.4e95.0), respectively.
Protocol Results
The total overall percentage of PC consults placed
before MCS implantation was 54.9% (67) from 2012
to 2015. The percentage of PC consults placed before
MCS implantation increased from 17.2% (11) before
protocol to 96.6% (56) after protocol (P < 0.0001)
and documented SDM increased 40.6% (26) before
protocol to 98.3% (57) after protocol (P < 0.0001;
Table 1). Of note, the proportion of documents
completed by the PC team (vs. previously completed)
did not change (80.8% vs. 79.0%. P ¼ 0.8487) as
shown in Table 1.
The use of the multidisciplinary PC team members
in the MCS population before and after implant
increased across all disciplines after protocol
(P < 0.0001). However, the distribution of team mem-
ber use before and after implant was found not to be
statistically different (P < 0.10), suggesting that team
members continued their involvement after implant
(Table 1).
In the total patient sample (n ¼ 122), 31 patients
(25.4%) were deceased as of data collection. There
were no statistical differences in the use of hospital-
based palliative care (P ¼ 0.2930) or hospice care
(P ¼ 0.2955) at the end of life between the pre-
protocol (n ¼ 19; 29.7%) and post-protocol (n ¼ 12;
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20.7%) samples. The majority of patients both before
protocol (84.2%) and after protocol (83.3%) died in
the hospital. Only two patients both before and after
protocol died at home (P ¼ 0.6547).
Discussion
We developed a collaborative protocol between the
PC and cardiology teams to include all patients under-
going evaluation for MCS. This was associated with
near 100% rate of PC evaluations completed before
MCS implantation and a substantial increase in the
number of patients with a documented SDM. The
Joint Commission has recommended the involvement
of PC evaluation for DT VAD implants.4 However, our
protocol was designed to include all MCS patients
given the knowledge that BTT patients have similar
needs for ACP and may get removed from the trans-
plant list based on complications or clinical changes.7
We used our electronic medical record system effec-
tively to generate an automated PC consult trigger
Table 1
Patient Demographics and Results
Patient Characteristics and Results
Pre-PC Protocol (n ¼ 64) Post-PC Protocol (n ¼ 58) Total (N ¼ 122)
P-Valuesan % n % n %
Age (range, mean) 24e75, 57.73 26e78, 54.86 24e78, 56.37 0.2200
Hospital length of stay (range,
mean)
13.2e148.9, 34.6 0.4e95, 34.2 0.4e148.9, 34.43 0.9837
Sex 0.0315
Male 39 60.9 46 79.3 85 69.7
Female 25 39.1 12 20.7 37 30.3
Race 0.6771
Caucasian 49 76.6 46 79.3 95 77.9
African American 14 21.9 9 15.5 23 18.9
Native Hawaiian or Pacific
Islander
0 0 1 1.7 1 0.8
Hispanic 0 0 1 1.7 1 0.8
Unknown 1 1.6 1 1.7 2 1.6
Education 0.8551
Some high school 5 7.9 7 12.5 12 9.8
High school/GED 32 50.8 26 46.4 8 6.6
<4 yrs college 18 28.6 17 30.4 19 15.6
College/graduate degree 8 12.7 6 10.7 11 9.0
Marital status 0.0497
Single 2 3.1 10 17.2 12 9.8
Significant other 4 6.3 5 8.6 9 7.4
Married 45 70.3 35 60.3 80 65.6
Separated 2 3.1 2 3.4 4 3.3
Divorced 7 10.9 6 10.3 13 10.7
Widowed 4 6.3 0 0 4 3.3
Type of therapy 0.8543
BTT 25 39.1 24 41.4 49 40.2
DT 39 60.9 34 58.6 73 59.8
MCS implanted 0.0091
HeartWare 12 18.8 23 39.7 35 28.7
HeartMateII 51 79.7 32 55.2 83 68.0
HeartMateIII 0 0 2 3.4 2 1.6
TAH 1 1.6 1 1.7 2 1.6
PC consult before implant 11 17.2 56 96.6 67 54.9 <0.0001
SDM documented before implant 26 40.6 57 98.3 83 68.0 <0.0001
SDM documents 0.8487
Completed with PC team 21 80.8 45 79.0 66 79.5
Preexisting documents 5 19.2 12 21.1 17 20.5
PC team member involvementb <0.10
Before MCS implant
Physicians 10 15.6 41 70.7 51 41.8 <0.0001
Advanced practice nurses 6 9.4 27 46.6 33 27.0 <0.0001
Social work 9 14.1 44 75.9 53 43.4 <0.0001
Chaplain 7 10.9 35 60.3 42 34.4 <0.0001
After MCS implant
Physicians 5 7.8 33 56.9 38 31.1 <0.0001
Advance practice nurses 5 7.8 26 44.8 31 25.4 <0.0001
Social work 9 14.1 50 86.2 59 48.4 <0.0001
Chaplain 7 10.9 35 60.3 42 34.4 <0.0001
PC ¼ palliative care; BTT ¼ bridge to transplant; DT ¼ destination therapy; MCS ¼mechanical circulatory support; TAH ¼ total artificial heart; SDM ¼ surrogate
decision maker.
aP-values are from Fisher’s exact tests for categorical variables, Student’s t-test for age, Wilcoxon nonparametric test for LOS.
bP-value from nonparametric two-sample Kolmogorov-Smirnov test.
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when a patient was identified. This guaranteed notifi-
cation of the PC consultation request for the MCS
population. The electronic medical record was also
used for documentation and storage of ACP/SDM
documents in a defined location to ensure easy and
consistent accessibility. We had a standardized struc-
ture for documenting the ACP that was influenced
by the preparedness plan as suggested by Swetz
et al.5 The basic requisite was to document patient
preferences for ACP, name and contact information
for SDM, and any symptoms needing to be addressed.
SDM documentation was used as a metric for our pro-
tocol success because the goal of ACP is to include pa-
tients in shared decision making and provide care in
accordance with their preferences. Identifying an
SDM is an important step to safeguard that patient
wishes for care are honored.8,9
While undergoing MCS implantation, patients are
under anesthesia for a significant time period and
on mechanical ventilation postoperatively. During
this time period, patients are unable to speak for
themselves. Patients may suffer minor or major com-
plications leaving them incapacitated and unable to
have complex medical discussions. Surrogacy laws
vary by state, and in Indiana, the laws are particularly
complex, with multiple family members having equal
authority in decision making. Patients are often un-
aware of these laws. Even with a well-developed ACP,
surrogates are needed to interpret patient preferences
and translate them into concrete medical decisions. By
identifying a legal SDM and including the SDM in the
ACP discussions, the goal is to ensure the patient’s
wishes are honored in such an event.
The development of this protocol identified a
growing need for outpatient follow-up to provide
symptom management and ongoing palliative sup-
port. Based on these observations, an outpatient
component to the collaboration has been established.
Although the Joint Commission recommends a PC
representative who has experience with the VAD pa-
tient population be part of the interdisciplinary team,
we provided a multidimensional approach of care to
the patients across the spectrum including needs
beyond ACP. We were additionally able to provide this
service to all patients under evaluation for MCS.
Challenges were identified in the implementation
of the protocol. One challenge was how to allocate re-
sources from an already busy service toward this
specialized group of patients. We limited this chal-
lenge by tailoring visits based on needs after the first
evaluation and by frequent chart reviews and close
collaboration with the primary cardiology team and
other staff. In addition, by using our multidisciplinary
approach effectively, we were able to limit the impact
of this challenge on our PC service. Limited time con-
straints within a hospital stay during MCS workup
added to the overwhelming amount of new staff mem-
bers introduced to the patient and their family were
also a challenge. An addition of an outpatient clinic
for earlier counseling and decision making was identi-
fied as beneficial. Future studies could replicate the
protocol at multiple centers using similar metrics for
success. Another area to explore is how PC can benefit
patients through psychosocial and symptom support
during the course of MCS implantation. A similar
model can be looked at in patients with serious illness
who are considering discrete interventions such as
renal replacement therapy, organ transplant, and any
major preoperative evaluations. Future research could
also ascertain protocol impact on a patient’s end-of-
life experience and care including the use of PC and
hospice services.
Limitations
The observations presented are from a relatively
small cohort limited to one institution and as such
would need to be validated by implementation in
different settings. In addition, the data were retrospec-
tive and based on chart review, and ongoing evalua-
tion of this protocol would be beneficial. The
mortality numbers in the given cohort were not large
enough to allow adequate assessment of benefits the
PC team provided in end-of-life care. In addition,
the cohort is too small to allow comparisons between
BTT and DT patients.
Conclusions
The results demonstrated that at a single institution,
an automated PC consult protocol and interdisci-
plinary consult approach for MCS candidates results
in completion of a PC consult and successful documen-
tation of an SDM with a high success rate. Close collab-
oration and amultidisciplinary approach were found to
be critical and fundamental to the success of this proto-
col. An integral element of the protocol was the
communication between the team clinical nurse coor-
dinators. An automated consultation trigger via the
electronic medical record along with documentation
within the electronic medical record proved beneficial.
The desired outcome from the multidisciplinary
approach was to provide care concordant with stated
goals, reduced symptom burden, and to improve
SDM education and documentation.
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